Literature DB >> 14962907

Clinical management of thrombophilia-related placental vascular complications.

Benjamin Brenner1.   

Abstract

Pregnancy is a hypercoagulable state with an increased thrombotic risk throughout gestation and the postpartum period. Women with thrombophilia may have a further increased risk of placental vascular complications, including pregnancy loss, preeclampsia, intrauterine growth restriction, and placental abruption. Preliminary data suggest that maternal antithrombotic prophylaxis may result in improved gestational outcome. Randomized trials are under way and hopefully will optimize maternal and neonatal outcome.

Entities:  

Mesh:

Year:  2004        PMID: 14962907     DOI: 10.1182/blood-2003-08-2744

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  3 in total

Review 1.  Anticoagulants in pregnancy.

Authors:  Ian A Greer
Journal:  J Thromb Thrombolysis       Date:  2006-02       Impact factor: 2.300

2.  The effect of maternal thrombophilia on placental abruption: Histologic correlates.

Authors:  Wendy L Kinzler; Vinay Prasad; Cande V Ananth
Journal:  J Matern Fetal Neonatal Med       Date:  2009-03

3.  Polymorphisms of F2, PROC, PROZ, and F13A1 Genes are Associated With Recurrent Spontaneous Abortion in Chinese Han Women.

Authors:  Zuying Xu; Ying Zhang; Wei Liu; Yunyun Liu; Yezhou Su; Qiong Xing; Xiaojin He; Zhaolian Wei; Yunxia Cao; Huifen Xiang
Journal:  Clin Appl Thromb Hemost       Date:  2018-01-24       Impact factor: 2.389

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.